Delivery Order SPE2DB25D3306-SPE2DB25FUASY

Award Date 1/29/25
Potential Completion Date 1/30/25
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $12,370.25, is for the delivery of 4561400770 - SPRYCEL 100 MG TABLET 30S, a pharmaceutical product. The award has a firm fixed price, with an ultimate completion date of July 5, 2023. This delivery order is not designated as a set-aside contract....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $23,322.22 firm-fixed-price delivery order contract is for the supply of SPRYCEL 100 MG TABLET 30S, a specialty medication. The contract has an ultimate completion date of January 3, 2025 and was awarded on January 2, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This federal contract award, with the ID SPE2DB22D1017|SPE2DB25FF2VW, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $12,157.79, is for the delivery of SPRYCEL 100 MG TABLET 30S, a specialty pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which is valued at...
This federal contract award, with ID SPE2DB22D6029|SPE2DB25FLUDP, was granted by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $16,519.86, is for the delivery of SPRYCEL 100 MG TABLET 30S, a pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award, with ID SPE2DB20D2104|SPE2DB24FU23R, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,115.92 firm fixed-price delivery order is for the supply of 4564661950 ! SPRYCEL 70 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of May 21, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $25,877.61, is for the delivery of SPRYCEL 100 MG TABLET 30S, a pharmaceutical product. The contract is a firm-fixed-price delivery order with a completion date of December 20, 2024. This award is not designated as a set-aside contract. In addition to this specific delivery...
This federal contract award, with ID SPE2DB22D3004|SPE2DB25FNP47, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,990.49 firm fixed-price delivery order is for the supply of SPRYCEL 100 MG TABLET 30S, a medication, to support military healthcare programs. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with...
This federal contract award, with an ID of SPE2DB22D2009|SPE2DB25FL7HK, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,974.93 delivery order contract is for the supply of SPRYCEL 100 MG TABLET 30S, a pharmaceutical product. The contract is a firm fixed-price, Indefinite Delivery Contract (IDC) that runs through January 15, 2025. This award is not designated as a set-aside contract....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SPRYCEL 70 MG TABLET 60S, valued at $12,196.84. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of January 6, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued...
This federal contract award, with an ID of SPE2DB22D2211|SPE2DB24FNLX5, was issued by the Defense Logistics Agency (DLA) and awarded to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of SPRYCEL 140 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $15,331.86 and a completion date of May 14, 2024. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and does not have a set-aside designation. Amerisourcebergen Drug Corp, a major...
  • SPE2DB25D3306
    Indefinite Delivery Contract
  • SPE2DB25D3306-SPE2DB25FUASY
    Delivery Order

This federal contract award is a delivery order (SPE2DB25D3306|SPE2DB25FUASY) with a ceiling value of $13,395.44, issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The award is for the supply of 4567090873 ! SPRYCEL 100 MG TABLET 30S, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has an ultimate completion date of January 30, 2025 and was awarded on January 29, 2025. The contract has a firm fixed price pricing type and does not have a set-aside designation, indicating open competition.

Generated 5/21/25, 10:00 AM